R. Labeque et al., ENZYMATIC MODIFICATION OF PLASMA LOW-DENSITY LIPOPROTEINS IN RABBITS - A POTENTIAL TREATMENT FOR HYPERCHOLESTEROLEMIA, Proceedings of the National Academy of Sciences of the United Statesof America, 90(8), 1993, pp. 3476-3480
Phospholipase A2 (EC 3.1.1.4) hydrolyzes certain phospholipids of low
density lipoprotein (LDL). Plasma clearance of phospholipase A2-modifi
ed human LDL is up to 17 times faster than that of native human LDL in
hypercholesterolemic rabbits. Modification of blood lipoproteins of h
ypercholesterolemic rabbits was performed by using an extracorporeal c
ircuit containing immobilized phospholipase A2. After 90-min treatment
s, nearly 30% decreases in plasma cholesterol concentrations were obse
rved. Erythrocyte, leukocyte, and platelet counts showed no net change
after treatment. This technique does not require any fluid replacemen
t or sorbent regeneration and offers a potential approach for lowering
serum cholesterol and LDL levels.